Skip Navigation



Europace Advance Access published online on May 13, 2008

Europace, doi:10.1093/europace/eun124
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/6/668    most recent
eun124v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schoonderwoerd, B. A.
Right arrow Articles by Van Gelder, I. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoonderwoerd, B. A.
Right arrow Articles by Van Gelder, I. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org


REVIEW

New risk factors for atrial fibrillation: causes of ‘not-so-lone atrial fibrillation’

Bas A. Schoonderwoerd1, Marcelle D. Smit1, Lucas Pen1 and Isabelle C. Van Gelder1,2,*

1 Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands; 2 The Interuniversity Cardiology Institute Netherlands, Utrecht, The Netherlands

Atrial fibrillation (AF) is a prevalent arrhythmia in patients with cardiovascular disease. The classical risk factors for developing AF include hypertension, valvular disease, (ischaemic) cardiomyopathy, diabetes mellitus, and thyroid disease. In some patients with AF, no underlying (cardiovascular) pathology is present and the aetiology remains unknown. This condition is known as lone AF. However, in recent years, other factors playing a role in the genesis of AF have gained attention, including obesity, sleep apnoea, alcohol abuse and other intoxications, excessive sports practice, latent hypertension, genetic factors, and inflammation. In this review, we address these ‘new risk factors’ (i.e. as opposed to the classical risk factors) and the mechanisms by which they lead to AF.

Key Words: Atrial fibrillation, Risk factors, Obesity, Alcohol, Inflammation, Exercise


* Corresponding author. Tel: +31 50 361 2355; fax: +31 50 361 4391. E-mail address: i.c.van.gelder{at}thorax.umcg.nl

Manuscript submitted 14 January 2008. Accepted after revision 18 April 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
N W F Linton and S W Dubrey
Narrow complex (supraventricular) tachycardias
Postgrad. Med. J., October 1, 2009; 85(1008): 546 - 551.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. D. Smit and I. C. Van Gelder
Will we be able to predict in which atrial fibrillation patients a rhythm control strategy will be successful?
Europace, July 1, 2009; 11(7): 846 - 847.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Laurent
Incidence of Atrial Fibrillation Among Aging Runners
Arch Intern Med, April 13, 2009; 169(7): 719 - 719.
[Full Text] [PDF]


Home page
CirculationHome page
D. Mozaffarian, C. D. Furberg, B. M. Psaty, and D. Siscovick
Response to Letter Regarding Article, "Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study"
Circulation, February 10, 2009; 119(5): e196 - e196.
[Full Text] [PDF]


Home page
EuropaceHome page
M. D. Smit and I. C. Van Gelder
Is inflammation a risk factor for recurrent atrial fibrillation?
Europace, February 1, 2009; 11(2): 138 - 139.
[Full Text] [PDF]


Home page
EuropaceHome page
L. Mont, R. Elosua, and J. Brugada
Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter
Europace, January 1, 2009; 11(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Shimano, R. Shibata, Y. Tsuji, Y. Inden, and T. Murohara
Homocysteine and heavy metal interactions in atrial fibrillation and ablation treatments: reply
Europace, December 1, 2008; 10(12): 1458 - 1459.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.